Maternal homocysteine in pregnancy and offspring birthweight: epidemiological associations and Mendelian

Chittaranjan S Yajnik1, Giriraj R Chandak2, Charudatta Joglekar3

  • 1Diabetes Unit, King Edward Memorial Hospital and Research Centre, Pune, India, CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India, Adjunct Group Leader, Adjunct Group, Genome Institute of Singapore, Singapore, Persistent Systems Ltd, Pune, India, Department of Nutrition, University of Oslo, Oslo, Norway, Department of Pharmacology, University of Oxford, Oxford, UK, Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India and MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK diabetes@kemdiabetes.org chandakgrc@ccmb.res.in.

Insights

High maternal homocysteine, linked to one-carbon metabolism, causally impacts fetal growth. Lowering maternal homocysteine levels may enhance fetal development and birthweight.

Area of Science:

  • Nutritional biochemistry
  • Maternal-fetal medicine
  • Genetics

Background:

  • Maternal one-carbon (1-C) metabolism disturbances are linked to poor fetal growth.
  • The causal relationship between maternal 1-C metabolism and fetal growth remains unestablished.

Purpose of the Study:

  • To investigate the association between maternal total homocysteine and offspring birthweight.
  • To test for causality using a Mendelian randomization framework.

Main Methods:

  • Studied maternal total homocysteine and offspring birthweight in Indian cohorts (Pune Maternal Nutrition Study and Parthenon Cohort Study).
  • Employed Mendelian randomization with the methylenetetrahydrofolatereductase (MTHFR) gene variant rs1801133 (677C→T).
  • Utilized instrumental variable and triangulation analysis, including meta-analysis.

Main Results:

  • Inverse relationship observed between maternal homocysteine and offspring birthweight (meta-analysis: -40 g/SD).
  • Maternal MTHFR risk genotype (rs1801133) predicted higher homocysteine and lower birthweight (meta-analysis: -61 g).
  • Instrumental variable and triangulation analyses supported a causal link.

Conclusions:

  • Findings suggest a causal role for maternal homocysteine in fetal growth.
  • Interventions to reduce maternal homocysteine concentrations may improve fetal development.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
62
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750